HomeOXB • LON
add
Oxford BioMedica plc
Nakaraang pagsara
GBX 299.50
Sakop ng araw
GBX 295.00 - GBX 309.50
Sakop ng taon
GBX 212.50 - GBX 455.00
Market cap
320.11M GBP
Average na Volume
311.64K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (GBP) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 39.00M | 67.80% |
Gastos sa pagpapatakbo | 21.82M | -16.95% |
Net na kita | -5.35M | 90.23% |
Net profit margin | -13.73 | 94.17% |
Kita sa bawat share | — | — |
EBITDA | -69.00K | 99.50% |
Aktuwal na % ng binabayarang buwis | -5.91% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (GBP) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 60.65M | -41.52% |
Kabuuang asset | 231.64M | -8.20% |
Kabuuang sagutin | 171.16M | -1.92% |
Kabuuang equity | 60.49M | — |
Natitirang share | 105.96M | — |
Presyo para makapag-book | 5.55 | — |
Return on assets | -4.62% | — |
Return on capital | -6.33% | — |
Cash Flow
Net change in cash
| (GBP) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -5.35M | 90.23% |
Cash mula sa mga operasyon | -5.73M | 50.37% |
Cash mula sa pag-invest | -827.00K | -261.68% |
Cash mula sa financing | -3.44M | -18.33% |
Net change in cash | -10.38M | 19.27% |
Malayang cash flow | 263.62K | 103.07% |
Tungkol
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange. Wikipedia
Itinatag
1995
Website
Mga Empleyado
861
